Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > HSPG2(Gene name) > Human
  • Add your favorite
  • HSPG2 (Gene name),
  • Basement membrane-specific heparan sulfate proteoglycan core protein (Protein name ),  PGBM_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    HSPG2;
    Protein name:
    Basement membrane-specific heparan sulfate proteoglycan core protein(HSPG);
    Alternative:
    Perlecan(PLC);
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Purified perlecan has a strong tendency to aggregate in dimers or stellate structures. It interacts with other basement membrane components such as laminin, prolargin and collagen type IV. Interacts with COL13A1, FGFBP1 and VWA1. Interacts (via C-terminus) with ECM1 (via C-terminus).
    Function:
    The LG3 peptide has anti-angiogenic properties that require binding of calcium ions for full activity.
    Subcellular Location:
    Secreted extracellular space extracellular matrix basement membrane
    Protein Attributes:
    Sequence length:
    4391
    Sequence:
    50:
    MGWRAAGALL | LALLLHGRLL | AVTHGLRAYD | GLSLPEDIET | VTASQMRWTH | 
    100:
    SYLSDDEDML | ADSISGDDLG | SGDLGSGDFQ | MVYFRALVNF | TRSIEYSPQL | 
    150:
    EDAGSREFRE | VSEAVVDTLE | SEYLKIPGDQ | VVSVVFIKEL | DGWVFVELDV | 
    200:
    GSEGNADGAQ | IQEMLLRVIS | SGSVASYVTS | PQGFQFRRLG | TVPQFPRACT | 
    250:
    EAEFACHSYN | ECVALEYRCD | RRPDCRDMSD | ELNCEEPVLG | ISPTFSLLVE | 
    300:
    TTSLPPRPET | TIMRQPPVTH | APQPLLPGSV | RPLPCGPQEA | ACRNGHCIPR | 
    350:
    DYLCDGQEDC | EDGSDELDCG | PPPPCEPNEF | PCGNGHCALK | LWRCDGDFDC | 
    400:
    EDRTDEANCP | TKRPEEVCGP | TQFRCVSTNM | CIPASFHCDE | ESDCPDRSDE | 
    450:
    FGCMPPQVVT | PPRESIQASR | GQTVTFTCVA | IGVPTPIINW | RLNWGHIPSH | 
    500:
    PRVTVTSEGG | RGTLIIRDVK | ESDQGAYTCE | AMNARGMVFG | IPDGVLELVP | 
    550:
    QRGPCPDGHF | YLEHSAACLP | CFCFGITSVC | QSTRRFRDQI | RLRFDQPDDF | 
    600:
    KGVNVTMPAQ | PGTPPLSSTQ | LQIDPSLHEF | QLVDLSRRFL | VHDSFWALPE | 
    650:
    QFLGNKVDSY | GGSLRYNVRY | ELARGMLEPV | QRPDVVLMGA | GYRLLSRGHT | 
    700:
    PTQPGALNQR | QVQFSEEHWV | HESGRPVQRA | ELLQVLQSLE | AVLIQTVYNT | 
    750:
    KMASVGLSDI | AMDTTVTHAT | SHGRAHSVEE | CRCPIGYSGL | SCESCDAHFT | 
    800:
    RVPGGPYLGT | CSGCNCNGHA | SSCDPVYGHC | LNCQHNTEGP | QCNKCKAGFF | 
    850:
    GDAMKATATS | CRPCPCPYID | ASRRFSDTCF | LDTDGQATCD | ACAPGYTGRR | 
    900:
    CESCAPGYEG | NPIQPGGKCR | PVNQEIVRCD | ERGSMGTSGE | ACRCKNNVVG | 
    950:
    RLCNECADGS | FHLSTRNPDG | CLKCFCMGVS | RHCTSSSWSR | AQLHGASEEP | 
    1000:
    GHFSLTNAAS | THTTNEGIFS | PTPGELGFSS | FHRLLSGPYF | WSLPSRFLGD | 
    1050:
    KVTSYGGELR | FTVTQRSQPG | STPLHGQPLV | VLQGNNIILE | HHVAQEPSPG | 
    1100:
    QPSTFIVPFR | EQAWQRPDGQ | PATREHLLMA | LAGIDTLLIR | ASYAQQPAES | 
    1150:
    RVSGISMDVA | VPEETGQDPA | LEVEQCSCPP | GYRGPSCQDC | DTGYTRTPSG | 
    1200:
    LYLGTCERCS | CHGHSEACEP | ETGACQGCQH | HTEGPRCEQC | QPGYYGDAQR | 
    1250:
    GTPQDCQLCP | CYGDPAAGQA | AHTCFLDTDG | HPTCDACSPG | HSGRHCERCA | 
    1300:
    PGYYGNPSQG | QPCQRDSQVP | GPIGCNCDPQ | GSVSSQCDAA | GQCQCKAQVE | 
    1350:
    GLTCSHCRPH | HFHLSASNPD | GCLPCFCMGI | TQQCASSAYT | RHLISTHFAP | 
    1400:
    GDFQGFALVN | PQRNSRLTGE | FTVEPVPEGA | QLSFGNFAQL | GHESFYWQLP | 
    1450:
    ETYQGDKVAA | YGGKLRYTLS | YTAGPQGSPL | SDPDVQITGN | NIMLVASQPA | 
    1500:
    LQGPERRSYE | IMFREEFWRR | PDGQPATREH | LLMALADLDE | LLIRATFSSV | 
    1550:
    PLAASISAVS | LEVAQPGPSN | RPRALEVEEC | RCPPGYIGLS | CQDCAPGYTR | 
    1600:
    TGSGLYLGHC | ELCECNGHSD | LCHPETGACS | QCQHNAAGEF | CELCAPGYYG | 
    1650:
    DATAGTPEDC | QPCACPLTNP | ENMFSRTCES | LGAGGYRCTA | CEPGYTGQYC | 
    1700:
    EQCGPGYVGN | PSVQGGQCLP | ETNQAPLVVE | VHPARSIVPQ | GGSHSLRCQV | 
    1750:
    SGSPPHYFYW | SREDGRPVPS | GTQQRHQGSE | LHFPSVQPSD | AGVYICTCRN | 
    1800:
    LHQSNTSRAE | LLVTEAPSKP | ITVTVEEQRS | QSVRPGADVT | FICTAKSKSP | 
    1850:
    AYTLVWTRLH | NGKLPTRAMD | FNGILTIRNV | QLSDAGTYVC | TGSNMFAMDQ | 
    1900:
    GTATLHVQAS | GTLSAPVVSI | HPPQLTVQPG | QLAEFRCSAT | GSPTPTLEWT | 
    1950:
    GGPGGQLPAK | AQIHGGILRL | PAVEPTDQAQ | YLCRAHSSAG | QQVARAVLHV | 
    2000:
    HGGGGPRVQV | SPERTQVHAG | RTVRLYCRAA | GVPSATITWR | KEGGSLPPQA | 
    2050:
    RSERTDIATL | LIPAITTADA | GFYLCVATSP | AGTAQARIQV | VVLSASDASP | 
    2100:
    PPVKIESSSP | SVTEGQTLDL | NCVVAGSAHA | QVTWYRRGGS | LPPHTQVHGS | 
    2150:
    RLRLPQVSPA | DSGEYVCRVE | NGSGPKEASI | TVSVLHGTHS | GPSYTPVPGS | 
    2200:
    TRPIRIEPSS | SHVAEGQTLD | LNCVVPGQAH | AQVTWHKRGG | SLPARHQTHG | 
    2250:
    SLLRLHQVTP | ADSGEYVCHV | VGTSGPLEAS | VLVTIEASVI | PGPIPPVRIE | 
    2300:
    SSSSTVAEGQ | TLDLSCVVAG | QAHAQVTWYK | RGGSLPARHQ | VRGSRLYIFQ | 
    2350:
    ASPADAGQYV | CRASNGMEAS | ITVTVTGTQG | ANLAYPAGST | QPIRIEPSSS | 
    2400:
    QVAEGQTLDL | NCVVPGQSHA | QVTWHKRGGS | LPVRHQTHGS | LLRLYQASPA | 
    2450:
    DSGEYVCRVL | GSSVPLEASV | LVTIEPAGSV | PALGVTPTVR | IESSSSQVAE | 
    2500:
    GQTLDLNCLV | AGQAHAQVTW | HKRGGSLPAR | HQVHGSRLRL | LQVTPADSGE | 
    2550:
    YVCRVVGSSG | TQEASVLVTI | QQRLSGSHSQ | GVAYPVRIES | SSASLANGHT | 
    2600:
    LDLNCLVASQ | APHTITWYKR | GGSLPSRHQI | VGSRLRIPQV | TPADSGEYVC | 
    2650:
    HVSNGAGSRE | TSLIVTIQGS | GSSHVPSVSP | PIRIESSSPT | VVEGQTLDLN | 
    2700:
    CVVARQPQAI | ITWYKRGGSL | PSRHQTHGSH | LRLHQMSVAD | SGEYVCRANN | 
    2750:
    NIDALEASIV | ISVSPSAGSP | SAPGSSMPIR | IESSSSHVAE | GETLDLNCVV | 
    2800:
    PGQAHAQVTW | HKRGGSLPSH | HQTRGSRLRL | HHVSPADSGE | YVCRVMGSSG | 
    2850:
    PLEASVLVTI | EASGSSAVHV | PAPGGAPPIR | IEPSSSRVAE | GQTLDLKCVV | 
    2900:
    PGQAHAQVTW | HKRGGNLPAR | HQVHGPLLRL | NQVSPADSGE | YSCQVTGSSG | 
    2950:
    TLEASVLVTI | EPSSPGPIPA | PGLAQPIYIE | ASSSHVTEGQ | TLDLNCVVPG | 
    3000:
    QAHAQVTWYK | RGGSLPARHQ | THGSQLRLHL | VSPADSGEYV | CRAASGPGPE | 
    3050:
    QEASFTVTVP | PSEGSSYRLR | SPVISIDPPS | STVQQGQDAS | FKCLIHDGAA | 
    3100:
    PISLEWKTRN | QELEDNVHIS | PNGSIITIVG | TRPSNHGTYR | CVASNAYGVA | 
    3150:
    QSVVNLSVHG | PPTVSVLPEG | PVWVKVGKAV | TLECVSAGEP | RSSARWTRIS | 
    3200:
    STPAKLEQRT | YGLMDSHAVL | QISSAKPSDA | GTYVCLAQNA | LGTAQKQVEV | 
    3250:
    IVDTGAMAPG | APQVQAEEAE | LTVEAGHTAT | LRCSATGSPA | PTIHWSKLRS | 
    3300:
    PLPWQHRLEG | DTLIIPRVAQ | QDSGQYICNA | TSPAGHAEAT | IILHVESPPY | 
    3350:
    ATTVPEHASV | QAGETVQLQC | LAHGTPPLTF | QWSRVGSSLP | GRATARNELL | 
    3400:
    HFERAAPEDS | GRYRCRVTNK | VGSAEAFAQL | LVQGPPGSLP | ATSIPAGSTP | 
    3450:
    TVQVTPQLET | KSIGASVEFH | CAVPSDRGTQ | LRWFKEGGQL | PPGHSVQDGV | 
    3500:
    LRIQNLDQSC | QGTYICQAHG | PWGKAQASAQ | LVIQALPSVL | INIRTSVQTV | 
    3550:
    VVGHAVEFEC | LALGDPKPQV | TWSKVGGHLR | PGIVQSGGVV | RIAHVELADA | 
    3600:
    GQYRCTATNA | AGTTQSHVLL | LVQALPQISM | PQEVRVPAGS | AAVFPCIASG | 
    3650:
    YPTPDISWSK | LDGSLPPDSR | LENNMLMLPS | VRPQDAGTYV | CTATNRQGKV | 
    3700:
    KAFAHLQVPE | RVVPYFTQTP | YSFLPLPTIK | DAYRKFEIKI | TFRPDSADGM | 
    3750:
    LLYNGQKRVP | GSPTNLANRQ | PDFISFGLVG | GRPEFRFDAG | SGMATIRHPT | 
    3800:
    PLALGHFHTV | TLLRSLTQGS | LIVGDLAPVN | GTSQGKFQGL | DLNEELYLGG | 
    3850:
    YPDYGAIPKA | GLSSGFIGCV | RELRIQGEEI | VFHDLNLTAH | GISHCPTCRD | 
    3900:
    RPCQNGGQCH | DSESSSYVCV | CPAGFTGSRC | EHSQALHCHP | EACGPDATCV | 
    3950:
    NRPDGRGYTC | RCHLGRSGLR | CEEGVTVTTP | SLSGAGSYLA | LPALTNTHHE | 
    4000:
    LRLDVEFKPL | APDGVLLFSG | GKSGPVEDFV | SLAMVGGHLE | FRYELGSGLA | 
    4050:
    VLRSAEPLAL | GRWHRVSAER | LNKDGSLRVN | GGRPVLRSSP | GKSQGLNLHT | 
    4100:
    LLYLGGVEPS | VPLSPATNMS | AHFRGCVGEV | SVNGKRLDLT | YSFLGSQGIG | 
    4150:
    QCYDSSPCER | QPCQHGATCM | PAGEYEFQCL | CRDGFKGDLC | EHEENPCQLR | 
    4200:
    EPCLHGGTCQ | GTRCLCLPGF | SGPRCQQGSG | HGIAESDWHL | EGSGGNDAPG | 
    4250:
    QYGAYFHDDG | FLAFPGHVFS | RSLPEVPETI | ELEVRTSTAS | GLLLWQGVEV | 
    4300:
    GEAGQGKDFI | SLGLQDGHLV | FRYQLGSGEA | RLVSEDPIND | GEWHRVTALR | 
    4350:
    EGRRGSIQVD | GEELVSGRSP | GPNVAVNAKG | SVYIGGAPDV | ATLTGGRFSS | 
    4391:
    GITGCVKNLV | LHSARPGAPP | PQPLDLQHRA | QAGANTRPCP | S
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    SMR:
    Pfam:
    KEGG:
    UniGene:
    String:
    MIM:
    Uniprot:
     
    FOR
    ELISA Kit for Human HSPG
    Cat.:
    E0565m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human HSPG
    Cat.:
    E0565h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human HSPG
    Cat.:
    U0565m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human HSPG
    Cat.:
    U0565h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human HSPG
    Cat.:
    P0565Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human HSPG
    Cat.:
    P0565Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human HSPG
    Monoclonal Antibody for Human HSPG
    Protein for Human HSPG
    Protein for Human HSPG

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor."
      Murdoch A.D. , Dodge G.R. , Cohen I. , Tuan R.S. , Iozzo R.V.
      J. Biol. Chem.267:8544-8557(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA];VARIANTS VAL-638; SER-765 AND VAL-1503
      tissue: Colon.
      tissue: Skin.
    2. 2.
      "Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor."
      Kallunki P. , Tryggvason K.
      J. Cell Biol.116:559-571(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA];VARIANTS VAL-638; SER-765; VAL-1503; HIS-2980; GLY-2995; THR-3168 AND GLN-3632
    3. 3.
      "The DNA sequence and biological annotation of human chromosome 1."
      Gregory S.G. , Barlow K.F. , McLay K.E. , Kaul R. , Swarbreck D. , Dunham A. , Scott C.E. , Howe K.L. , Woodfine K. , Spencer C.C.A. , Jones M.C. , Gillson C. , Searle S. , Zhou Y. , Kokocinski F. , McDonald L. , Evans R. , Phillips K. , more...
      Nature441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    4. 4.
      "Structural characterization of the complete human perlecan gene and its promoter."
      Cohen I.R. , Graessel S. , Murdoch A.D. , Iozzo R.V.
      Proc. Natl. Acad. Sci. U.S.A.90:10404-10408(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21
    5. 5.
      "Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)."
      Nicole S. , Davoine C.-S. , Topaloglu H. , Cattolico L. , Barral D. , Beighton P. , Ben-Hamida C. , Hammouda H. , Cruaud C. , White P.S. , Samson D. , Urtizberea J.A. , Lehmann-Horn F. , Weissenbach J. , Hentati F. , Fontaine B.
      Nat. Genet.26:480-483(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 22-4391;VARIANTS VAL-638 AND SJS1 TYR-1532;VARIANTS SER-765 AND VAL-1503
    6. 6.
      "Cloning of human heparan sulfate proteoglycan core protein, assignment of the gene (HSPG2) to 1p36.1-->p35 and identification of a BamHI restriction fragment length polymorphism."
      Kallunki P. , Eddy R.L. , Byers M.G. , Kestila M. , Shows T.B. , Tryggvason K.
      Genomics11:389-396(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 890-1396
      tissue: Fibrosarcoma.
    7. 7.
      "Heparan sulfate proteoglycan of human colon: partial molecular cloning, cellular expression, and mapping of the gene (HSPG2) to the short arm of human chromosome 1."
      Dodge G.R. , Kovalszky I. , Chu M.-L. , Hassell J.R. , McBride O.W. , Yi H.F. , Iozzo R.V.
      Genomics10:673-680(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1016-1470
      tissue: Colon.
    8. 8.
      "Matrix-associated heparan sulfate proteoglycan: core protein-specific monoclonal antibodies decorate the pericellular matrix of connective tissue cells and the stromal side of basement membranes."
      Heremans A. , van der Schueren B. , de Cock B. , Paulsson M. , Cassiman J.-J. , van den Berghe H. , David G.
      J. Cell Biol.109:3199-3211(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 1379-1398 AND 2259-2278
    9. 9.
      "BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan."
      Gonzalez E.M. , Reed C.C. , Bix G. , Fu J. , Zhang Y. , Gopalakrishnan B. , Greenspan D.S. , Iozzo R.V.
      J. Biol. Chem.280:7080-7087(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 4197-4208;PROTEOLYTIC PROCESSING AT ASN-4196;FUNCTION OF LG3 PEPTIDE;GLYCOSYLATION;MUTAGENESIS OF ASP-4197; ASP-4258 AND ASN-4327
    10. 10.
      "Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan."
      Mongiat M. , Sweeney S.M. , San Antonio J.D. , Fu J. , Iozzo R.V.
      J. Biol. Chem.278:4238-4249(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 4197-4203;PROTEOLYTIC PROCESSING AT ASN-4196;FUNCTION OF ENDOREPELLIN AND LG3 PEPTIDE
    11. 11.
      "Fibroblast growth factor-binding protein is a novel partner for perlecan protein core."
      Mongiat M. , Otto J. , Oldershaw R. , Ferrer F. , Sato J.D. , Iozzo R.V.
      J. Biol. Chem.276:10263-10271(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH FGFBP1
    12. 12.
      "Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene."
      Arikawa-Hirasawa E. , Wilcox W.R. , Le A.H. , Silverman N. , Govindraj P. , Hassell J.R. , Yamada Y.
      Nat. Genet.27:431-434(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN DDSH
    13. 13.
      "The type XIII collagen ectodomain is a 150-nm rod and capable of binding to fibronectin, nidogen-2, perlecan, and heparin."
      Tu H. , Sasaki T. , Snellman A. , Gohring W. , Pirila P. , Timpl R. , Pihlajaniemi T.
      J. Biol. Chem.277:23092-23099(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH COL13A1
    14. 14.
      "Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis."
      Mongiat M. , Fu J. , Oldershaw R. , Greenhalgh R. , Gown A.M. , Iozzo R.V.
      J. Biol. Chem.278:17491-17499(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH ECM1
    15. 15.
      "Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry."
      Zhang H. , Li X.-J. , Martin D.B. , Aebersold R.
      Nat. Biotechnol.21:660-666(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION AT ASN-2121
    16. 16.
      "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry."
      Liu T. , Qian W.-J. , Gritsenko M.A. , Camp D.G. II , Monroe M.E. , Moore R.J. , Smith R.D.
      J. Proteome Res.4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1755
      tissue: Plasma.
    17. 17.
      "Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism."
      Bix G. , Castello R. , Burrows M. , Zoeller J.J. , Weech M. , Iozzo R.A. , Cardi C. , Thakur M.L. , Barker C.A. , Camphausen K. , Iozzo R.V.
      J. Natl. Cancer Inst.98:1634-1646(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION OF ENDOREPELLIN
    18. 18.
      "Integrin alpha2beta1 is the required receptor for endorepellin angiostatic activity."
      Woodall B.P. , Nystroem A. , Iozzo R.A. , Eble J.A. , Niland S. , Krieg T. , Eckes B. , Pozzi A. , Iozzo R.V.
      J. Biol. Chem.283:2335-2343(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION OF ENDOREPELLIN;IDENTIFICATION OF RECEPTOR
    19. 19.
      "Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity."
      Nystrom A. , Shaik Z.P. , Gullberg D. , Krieg T. , Eckes B. , Zent R. , Pozzi A. , Iozzo R.V.
      Blood114:4897-4906(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION
    20. 20.
      "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
      Chen R. , Jiang X. , Sun D. , Han G. , Wang F. , Ye M. , Wang L. , Zou H.
      J. Proteome Res.8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-554; ASN-1755; ASN-3072; ASN-3780; ASN-3836 AND ASN-4068
      tissue: Liver.
    21. 21.
      "Human urinary glycoproteomics; attachment site specific analysis of N-and O-linked glycosylations by CID and ECD."
      Halim A. , Nilsson J. , Ruetschi U. , Hesse C. , Larson G.
      Mol. Cell. Proteomics0:0-0(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION AT THR-42;STRUCTURE OF CARBOHYDRATES;IDENTIFICATION BY MASS SPECTROMETRY
    22. 22.
      "Crystal structure of the LG3 domain of endorepellin, an angiogenesis inhibitor."
      Le B.V. , Kim H. , Choi J. , Kim J.H. , Hahn M.J. , Lee C. , Kim K.K. , Hwang H.Y.
      J. Mol. Biol.414:231-242(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 4197-4391;DISULFIDE BOND;CALCIUM-BINDING SITES
    Product Feedback Wall
    Hot Genes
    Top Searches
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter